By removing the protein galectin-3 (Gal3), a team of investigators led by University of California School of Medicine researchers were able to reverse diabetic insulin resistance and glucose intolerance in mouse models of obesity and diabetes. … Read the Full Story from the UC San Diego Newsroom

Dr. Jerrold Olefsky

Dr. Jerrold Olefsky

Dr. Jerrold Olefsky, Professor of Medicine in the Division of Endocrinology and Metabolism in the School of Medicine at UC San Diego, is principal investigator of this international study.

Read the Study Report (Full Content, UCSD Only)

See Dr. Olefsky’s Research Profile

%d bloggers like this: